<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[Vifor Pharma Ltd. 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=37639></link><description><![CDATA[Vifor Pharma Ltd. 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Fri, 01 May 2026 04:58:03 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2021/05/12_3554238800_20210507153309_8664371262.jpg]]></url></image><language>ko-KR</language><item><title><![CDATA[Vifor Pharma reports sustained growth in 2021]]></title><link>https://www.newswire.co.kr/newsRead.php?no=939727</link><description><![CDATA[ST. GALLEN, Switzerland--(Business Wire/Korea Newswire)--Regulatory News:  AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR  Vifor Pharma Group reported a solid performance in 2021 and an increase in profitability, supported by a strong recovery in Ferinject® / Injectafer® sales from the second quarter 2021 on, and sustained by positive momentum in the second half of 2021.  FINANCIAL PERFORMANCE: SOLID PERF...]]></description><pubDate>Thu, 17 Feb 2022 15:20:44 +0900</pubDate></item><item><title><![CDATA[CSL Behring AG publishes Offer Prospectus on public tender offer for all publicly held shares of Vifor Pharma Ltd.]]></title><link>https://www.newswire.co.kr/newsRead.php?no=938299</link><description><![CDATA[MELBOURNE, Australia & ST. GALLEN, Switzerland--(Business Wire/Korea Newswire)--Regulatory News:  AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR  CSL Behring AG, Berne, Switzerland, a wholly-owned subsidiary of global biotechnology leader CSL Limited (ASX: CSL; USOTC: CSLLY), today published the offer prospectus regarding its public tender offer for all publicly held registered shares of Vifor Pharma Ltd. (SIX:VIFN; ISIN:CH0364...]]></description><pubDate>Tue, 18 Jan 2022 15:50:00 +0900</pubDate></item><item><title><![CDATA[93rd Vifor Pharma Group Annual General Meeting]]></title><link>https://www.newswire.co.kr/newsRead.php?no=922977</link><description><![CDATA[ST. GALLEN, Switzerland--(Business Wire/Korea Newswire)--Regulatory News:  At today’s 93rd Annual General Meeting of Vifor Pharma Ltd., shareholders approved all proposed resolutions put forward by the Board of Directors. In view of the ongoing COVID-19 pandemic and in accordance with Ordinance 3 on measures to combat the coronavirus issued by the Swiss Federal Council, on the basis of Art. 8 of the n...]]></description><pubDate>Fri, 07 May 2021 16:00:00 +0900</pubDate></item></channel></rss>